[Multiple sites extrapodal actinomycetoma: Favorable outcome to treatment with a combination of cotrimoxazole and NSAI]

J Mycol Med. 2015 Dec;25(4):297-302. doi: 10.1016/j.mycmed.2015.09.006. Epub 2015 Nov 5.
[Article in French]

Abstract

Mycetoma is a bacteriological or fungal infectious disease affecting the skin and/or soft tissues, which can be complicated by bone involvement. The most common feature is a tumor of the foot, but extrapodal localizations have been described. We report one case of a 47-year-old man who presented with tumefaction of a leg with multiple skin fistulae. Histopathological examination permitted to confirm the diagnosis of actinomycetoma and TDM showed the degree of bone and soft tissues involvement. Our case was characterized by the very inflammatory aspect of the tumor, its localization to the leg without foot involvement, the modest functional signs compared to the importance of radiological bone involvements, the deep destruction of the fibula while the tibia was apparently intact and the good response to treatment. In spite of its characteristic features, diagnosis of mycetoma is still late in our country, often with bone and/or articular spread. Priority may be given to measures for reduction of mycetoma diagnosis lateness.

Keywords: Actinomycosique; Actinomycotic; Atteinte osseuse; Bone involvement; Jambe; Leg; Mycetoma; Mycétome.

Publication types

  • Case Reports

MeSH terms

  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
  • Bone Diseases, Infectious / drug therapy
  • Bone Diseases, Infectious / microbiology
  • Bone Diseases, Infectious / pathology
  • Cutaneous Fistula / drug therapy
  • Cutaneous Fistula / microbiology
  • Cutaneous Fistula / pathology
  • Delayed Diagnosis
  • Diclofenac / therapeutic use*
  • Humans
  • Leg / microbiology
  • Leg / pathology
  • Male
  • Middle Aged
  • Mycetoma / complications
  • Mycetoma / drug therapy*
  • Mycetoma / pathology
  • Osteolysis / drug therapy
  • Osteolysis / microbiology
  • Osteolysis / pathology
  • Treatment Outcome
  • Trimethoprim, Sulfamethoxazole Drug Combination / therapeutic use*

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Diclofenac
  • Trimethoprim, Sulfamethoxazole Drug Combination